Fennec Sues Cipla Over Generic Hearing Loss Treatment Bid
Biotechnology company Fennec Pharmaceuticals and an Oregon university have accused an Indian company of infringing a trio of patents on a therapy to treat hearing loss in children undergoing chemotherapy....To view the full article, register now.
Already a subscriber? Click here to view full article